Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Confidence Limits for the Indirect Effect: Distribution of the Product and Resampling Methods.

Mackinnon DP, Lockwood CM, Williams J.

Multivariate Behav Res. 2004 Jan 1;39(1):99.

2.

A simple single-item rating scale to measure medication adherence: further evidence for convergent validity.

Kalichman SC, Amaral CM, Swetzes C, Jones M, Macy R, Kalichman MO, Cherry C.

J Int Assoc Physicians AIDS Care (Chic). 2009 Nov-Dec;8(6):367-74. doi: 10.1177/1545109709352884.

3.

Contributors to neuropsychological impairment in HIV-infected and HIV-uninfected opiate-dependent patients.

Applebaum AJ, Otto MW, Richardson MA, Safren SA.

J Clin Exp Neuropsychol. 2010 Jul;32(6):579-89. doi: 10.1080/13803390903313572. Epub 2010 Nov 4.

4.

Numeracy skills explain racial differences in HIV medication management.

Waldrop-Valverde D, Osborn CY, Rodriguez A, Rothman RL, Kumar M, Jones DL.

AIDS Behav. 2010 Aug;14(4):799-806. doi: 10.1007/s10461-009-9604-4. Epub 2009 Aug 8.

5.

The impact of neuropsychological functioning on adherence to HAART in HIV-infected substance abuse patients.

Applebaum AJ, Reilly LC, Gonzalez JS, Richardson MA, Leveroni CL, Safren SA.

AIDS Patient Care STDS. 2009 Jun;23(6):455-62. doi: 10.1089/apc.2008.0181.

6.

Elevated cortisol and learning and memory deficits in cocaine dependent individuals: relationship to relapse outcomes.

Fox HC, Jackson ED, Sinha R.

Psychoneuroendocrinology. 2009 Sep;34(8):1198-207. doi: 10.1016/j.psyneuen.2009.03.007. Epub 2009 Apr 16.

7.

Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users.

Baum MK, Rafie C, Lai S, Sales S, Page B, Campa A.

J Acquir Immune Defic Syndr. 2009 Jan 1;50(1):93-9. doi: 10.1097/QAI.0b013e3181900129.

PMID:
19295339
8.

The relationship between neuropsychological functioning and HAART adherence in HIV-positive adults: a systematic review.

Lovejoy TI, Suhr JA.

J Behav Med. 2009 Oct;32(5):389-405. doi: 10.1007/s10865-009-9212-9. Epub 2009 Mar 17. Review.

PMID:
19291386
9.

Health-related quality of life in HIV-infected patients: the role of substance use.

Korthuis PT, Zephyrin LC, Fleishman JA, Saha S, Josephs JS, McGrath MM, Hellinger J, Gebo KA; HIV Research Network.

AIDS Patient Care STDS. 2008 Nov;22(11):859-67. doi: 10.1089/apc.2008.0005.

10.

The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.

Roux P, Carrieri MP, Villes V, Dellamonica P, Poizot-Martin I, Ravaux I, Spire B; MANIF2000 cohort study group.

Addiction. 2008 Nov;103(11):1828-36. doi: 10.1111/j.1360-0443.2008.02323.x. Epub 2008 Sep 4.

PMID:
18778390
11.

Gender differences in medication management capacity in HIV infection: the role of health literacy and numeracy.

Waldrop-Valverde D, Jones DL, Jayaweera D, Gonzalez P, Romero J, Ownby RL.

AIDS Behav. 2009 Feb;13(1):46-52. doi: 10.1007/s10461-008-9425-x. Epub 2008 Jul 10.

12.

Variable patterns of neuropsychological performance in HIV-1 infection.

Dawes S, Suarez P, Casey CY, Cherner M, Marcotte TD, Letendre S, Grant I, Heaton RK; HNRC Group.

J Clin Exp Neuropsychol. 2008 Aug;30(6):613-26. doi: 10.1080/13803390701565225. Epub 2008 Mar 4.

13.

Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse.

Chang L, Wang GJ, Volkow ND, Ernst T, Telang F, Logan J, Fowler JS.

Neuroimage. 2008 Aug 15;42(2):869-78. doi: 10.1016/j.neuroimage.2008.05.011. Epub 2008 May 20.

14.

Alcohol use among HIV-infected persons in care: results of a multi-site survey.

Chander G, Josephs J, Fleishman JA, Korthuis PT, Gaist P, Hellinger J, Gebo K; HIV Research Network.

HIV Med. 2008 Apr;9(4):196-202. doi: 10.1111/j.1468-1293.2008.00545.x.

15.

The Neuropathology of HIV/AIDS.

Anthony IC, Bell JE.

Int Rev Psychiatry. 2008 Feb;20(1):15-24. doi: 10.1080/09540260701862037. Review.

PMID:
18240059
16.

Neurobiology of HIV.

Hult B, Chana G, Masliah E, Everall I.

Int Rev Psychiatry. 2008 Feb;20(1):3-13. doi: 10.1080/09540260701862086. Review.

PMID:
18240058
17.

Optimizing measurement of self-reported adherence with the ACTG Adherence Questionnaire: a cross-protocol analysis.

Reynolds NR, Sun J, Nagaraja HN, Gifford AL, Wu AW, Chesney MA.

J Acquir Immune Defic Syndr. 2007 Dec 1;46(4):402-9.

PMID:
18077832
18.

Updated research nosology for HIV-associated neurocognitive disorders.

Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE.

Neurology. 2007 Oct 30;69(18):1789-99. Epub 2007 Oct 3.

19.

Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study.

Schifitto G, Navia BA, Yiannoutsos CT, Marra CM, Chang L, Ernst T, Jarvik JG, Miller EN, Singer EJ, Ellis RJ, Kolson DL, Simpson D, Nath A, Berger J, Shriver SL, Millar LL, Colquhoun D, Lenkinski R, Gonzalez RG, Lipton SA; Adult AIDS Clinical Trial Group (ACTG) 301; 700 Teams; HIV MRS Consortium.

AIDS. 2007 Sep 12;21(14):1877-86.

PMID:
17721095
20.

Supplemental Content

Support Center